Last week, one of China’s largest vaccine makers, Changchun Changsheng Biotechnology, was exposed...
- Big soil: Genentech and Lodo launch $1bn project to develop new drugs from earth
- Results from investigation into Chinese Changsheng’s rabies vaccine scandal unveiled
- Oxford Genetics signs agreement for CRISPR cell lines with global e-commerce company
- The next generation of antimalarials
- Medicines for Malaria Venture: steps towards eliminating a global scourge
Innovations in API Solubility and Bioavailability
API solubility and bioavailability, new technology for pharmaceutical products, twin screw technology, melt granulation and kneading and conveying, etc ... are all topics that are covered in this white paper.
So you want to break into the Chinese vaccine market?
Last week, one of China’s largest vaccine makers, Changchun Changsheng Biotechnology, was exposed for selling and distributing hundreds of thousands of faulty vaccines for children.
After Zavante deal, Nabriva is poised to launch two first-in-class antibiotics
On July 24, Nabriva Therapeutics announced the acquisition of Zavante Therapeutics, a biotechnology company developing treatments for the infections that threaten hospitalized patients.
New Strategies to Promote Compliance and Inspection Readiness
Join trial management file (TMF) experts and industry professionals for a series of informative sessions and panel discussions on the topics that matter in TMF management.
Getting to the Bottom of Data Integrity: Four to Explore
NSF International Pharma has experienced that data integrity (DI) is usually the tip of a very big iceberg. Beneath the surface can be a number of contributing factors, rarely just one.
Big soil: Genentech and Lodo launch $1bn project to develop new drugs from earth
Genentech has signed a $1bn open-ended drug discovery collaboration with Lodo Therapeutics to develop unique, natural products from the microbial DNA found in soil. Genentech will use Lodo’s metagenome-prospecting platform to identify novel small molecules with the potential for treating disease. With this level of investment confidence must be high, but just how much potential lies in soil, and how can it be harnessed?
Huber Kältemaschinenbau Opens New Subsidiary in China
Peter Huber Kältemaschinenbau has continued its international expansion by opening a new sales office based in Guangzhou, China. The new subsidiary will serve end users and dealers in the country under the name Huber China.
Fast and Reliable Quantification of Data
Omnian was developed for Malvern Panalytical's high-end x-ray fluorescence (XRD) spectrometer and is also available for the Epsilon 4 energy dispersive x-ray fluorescence (EDXRF) benchtop systems. This powerful combination brings together the strengths of Omnian with the ease-of-use of Epsilon 4.
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.